NIAID Banner Logo Image

Opportunistic Infections Citation List: May 10 - May 23, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Differences in Composition of Honey Samples and Their Impact on the Antimicrobial Activities against Drug Multiresistant Bacteria and Pathogenic Fungi. Al-Waili, N., A. Al Ghamdi, M.J. Ansari, Y. Al-Attar, A. Osman, and K. Salom. Archives of Medical Research, 2013. [Epub ahead of print]. PMID[23684665].

[PubMed]. OI_0510-052313.


2. Synthesis and Antimicrobial Activity of Novel Amphiphilic Aromatic Amino Alcohols. de Almeida, A.M., T. Nascimento, B.S. Ferreira, P.P. de Castro, V.L. Silva, C.G. Diniz, and M. Le Hyaric. Bioorganic & Medicinal Chemistry Letters, 2013. 23(10): p. 2883-2887. PMID[23587426].

[PubMed]. OI_0510-052313.


3. Synthesis and Biological Evaluation of Some Novel Urea and Thiourea Derivatives of Isoxazolo[4,5-d]pyridazine and Structurally Related Thiazolo[4,5-d]pyridazine as Antimicrobial Agents. Faidallah, H.M., S.A. Rostom, S.A. Basaif, M.S. Makki, and K.A. Khan. Archives of Pharmacal Research, 2013. [Epub ahead of print]. PMID[23657806].

[PubMed]. OI_0510-052313.


4. Antimicrobial Activity of Schinus lentiscifolius (Anacardiaceae). Gehrke, I.T., A.T. Neto, M. Pedroso, C.P. Mostardeiro, I.B. Manica Da Cruz, U.F. Silva, V. Ilha, Dalcol, II, and A.F. Morel. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23684720].

[PubMed]. OI_0510-052313.


5. Identification and Mechanism of Action of the Plant Defensin NaD1 as a New Member of the Antifungal Drug Arsenal against Candida albicans. Hayes, B.M., M.R. Bleackley, J.L. Wiltshire, M.A. Anderson, A. Traven, and N.L. van der Weerden. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23689717].

[PubMed]. OI_0510-052313.


6. Potentiation of Azole Antifungals by 2-Adamantanamine. Lafleur, M.D., L. Sun, I. Lister, J. Keating, A. Nantel, L. Long, M. Ghannoum, J. North, R.E. Lee, K. Coleman, T. Dahl, and K. Lewis. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23689724].

[PubMed]. OI_0510-052313.


7. Antimicrobial Activity and Cytotoxicity of Triterpenes Isolated from Leaves of Maytenus undata (Celastraceae). Mokoka, T.A., L.J. McGaw, L.K. Mdee, V.P. Bagla, E.O. Iwalewa, and J.N. Eloff. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 111. PMID[23688235].

[PubMed]. OI_0510-052313.


8. Synthesis and Biological Evaluation of Pyrazoline Derivatives Bearing an Indole Moiety as New Antimicrobial Agents. Ozdemir, A., M.D. Altintop, Z.A. Kaplancikli, G. Turan-Zitouni, H. Karaca, and Y. Tunali. Archiv der Pharmazie, 2013. [Epub ahead of print]. PMID[23681942].

[PubMed]. OI_0510-052313.


9. High-throughput Screening of a Collection of Known Pharmacologically Active Small Compounds for the Identification of Candida albicans Biofilm Inhibitors. Siles, S.A., A. Srinivasan, C.G. Pierce, J.L. Lopez-Ribot, and A.K. Ramasubramanian. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23689719].

[PubMed]. OI_0510-052313.


10. Effects of Chirality on the Antifungal Potency of Methylated Succinimides Obtained by Aspergillus fumigatus Biotransformations. Comparison with Racemic Ones. Sortino, M., A. Postigo, and S. Zacchino. Molecules, 2013. 18(5): p. 5669-5683. PMID[23676473].

[PubMed]. OI_0510-052313.


11. Anti-aspergillus Activity of Green Coffee 5-O-Caffeoyl quinic acid and Its Alkyl Esters. Suarez-Quiroz, M.L., A. Alonso Campos, G. Valerio Alfaro, O. Gonzalez-Rios, P. Villeneuve, and M.C. Figueroa-Espinoza. Microbial Pathogenesis, 2013. [Epub ahead of print]. PMID[23684728].

[PubMed]. OI_0510-052313.


12. Antifungal Attributes of Siderophore Produced by the Pseudomonas aeruginosa JAS-25. Sulochana, M.B., S.Y. Jayachandra, S.K. Kumar, and A. Dayanand. Journal of Basic Microbiology, 2013. [Epub ahead of print]. PMID[23686966].

[PubMed]. OI_0510-052313.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

13. Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis PanK. Bjorkelid, C., T. Bergfors, A.K. Raichurkar, K. Mukherjee, K. Malolanarasimhan, B. Bandodkar, and T.A. Jones. The Journal of Biological Chemistry, 2013. [Epub ahead of print]. PMID[23661699].

[PubMed]. OI_0510-052313.


14. Antiprotozoal and Antimycobacterial Activities of Persea americana Seeds. Jimenez-Arellanes, A., J. Luna-Herrera, R. Ruiz-Nicolas, J. Cornejo-Garrido, A. Tapia, and L. Yepez-Mulia. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 109. PMID[23680126].

[PubMed]. OI_0510-052313.


15. Identification of M. tuberculosis Thioredoxin Reductase Inhibitors Based on High-throughput Docking Using Constraints. Koch, O., T. Jaeger, K. Heller, P.C. Khandavalli, J. Pretzel, K. Becker, L. Flohe, and P.M. Selzer. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23676086].

[PubMed]. OI_0510-052313.


16. Inhibition of Mycobacterial Alanine Racemase Activity and Growth by Thiadiazolidinones. Lee, Y., S. Mootien, C. Shoen, M. Destefano, P. Cirillo, O.A. Asojo, K.R. Yeung, M. Ledizet, M.H. Cynamon, P.A. Aristoff, R.A. Koski, P.A. Kaplan, and K.G. Anthony. Biochemical Pharmacology, 2013. [Epub ahead of print]. PMID[23680030].

[PubMed]. OI_0510-052313.


17. Antitubercular Diterpenoids from Vitex trifolia. Tiwari, N., J. Thakur, D. Saikia, and M.M. Gupta. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 2013. 20(7): p. 605-610. PMID[23462211].

[PubMed]. OI_0510-052313.


18. In Vitro Activities of PNU-100480 and Linezolid against Drug-susceptible and Drug-resistant Mycobacterium tuberculosis Isolates. Yip, P.C., K.M. Kam, E.T. Lam, R.C. Chan, and W.W. Yew. International Journal of Antimicrobial Agents, 2013. [Epub ahead of print]. PMID[23684005].

[PubMed]. OI_0510-052313.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

19. Substituted Imidazopyridazines Are Potent and Selective Inhibitors of Plasmodium falciparum Calcium-dependent Protein Kinase 1 (PfCDPK1). Chapman, T.M., S.A. Osborne, N. Bouloc, J.M. Large, C. Wallace, K. Birchall, K.H. Ansell, H.M. Jones, D. Taylor, B. Clough, J.L. Green, and A.A. Holder. Bioorganic & Medicinal Chemistry Letters, 2013. 23(10): p. 3064-3069. PMID[23570789].

[PubMed]. OI_0510-052313.


26. Antiplasmodial and Anti-inflammatory Activities of Canthium henriquesianum (K. Schum), a Plant Used in Traditional Medicine in Burkina Faso. Ilboudo, D.P., N. Basilico, S. Parapini, Y. Corbett, S. D'Alessandro, M. Dell'agli, P. Coghi, S.D. Karou, R. Sawadogo, C. Gnoula, J. Simpore, J.B. Nikiema, D. Monti, E. Bosisio, and D. Taramelli. Journal of Ethnopharmacology, 2013. [Epub ahead of print]. PMID[23680158].

[PubMed]. OI_0510-052313.


21. Broad Spectrum Antimalarial Activity of Peptido sulfonyl fluorides, a New Class of Proteasome Inhibitors. Tschan, S., A.J. Brouwer, P.R. Werkhoven, A.M. Jonker, L. Wagner, S. Knittel, M.N. Aminake, G. Pradel, F. Joanny, R.M. Liskamp, and B. Mordmuller. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23689711].

[PubMed]. OI_0510-052313.

ANTIPROTOZOAL COMPOUNDS

22. In Vitro Evaluation of beta-Carboline Alkaloids as Potential Anti-toxoplasma Agents. Alomar, M.L., F.A. Rasse-Suriani, A. Ganuza, V.M. Coceres, F.M. Cabrerizo, and S.O. Angel. BMC Research Notes, 2013. 6: p. 193. PMID[23663567].

[PubMed]. OI_0510-052313.


23. Optimization of Benzoxazole-based Inhibitors of Cryptosporidium parvum Inosine 5'-Monophosphate Dehydrogenase. Gorla, S.K., M. Kavitha, M. Zhang, J.E. Chin, X. Liu, B. Striepen, M. Makowska-Grzyska, Y. Kim, A. Joachimiak, L. Hedstrom, and G.D. Cuny. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23668331].

[PubMed]. OI_0510-052313.


24. Regulation of IDO Activity by Oxygen Supply: Inhibitory Effects on Antimicrobial and Immunoregulatory Functions. Schmidt, S.K., S. Ebel, E. Keil, C. Woite, J.F. Ernst, A.E. Benzin, J. Rupp, and W. Daubener. Plos One, 2013. 8(5): p. e63301. PMID[23675474].

[PubMed]. OI_0510-052313.

Citations from the ISI Web of Knowledge Listings for O.I.

25. Evaluation of Antimycobacterial Activity of a Sulphonamide Derivative. Agertt, V.A., L.L. Marques, P.C. Bonez, T.V. Dalmolin, G.N. Manzoni de Oliveira, and M.M. Anraku de Campos. Tuberculosis, 2013. 93(3): p. 318-321. ISI[000317183000010].

[WOS]. OI_0510-052313.


26. Coumarinyl Pyrazole Derivatives of Inh: Promising Antimycobacterial Agents. Aragade, P., M. Palkar, P. Ronad, and D. Satyanarayana. Medicinal Chemistry Research, 2013. 22(5): p. 2279-2283. ISI[000316912800024].

[WOS]. OI_0510-052313.


27. Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-inflammatory, Analgesic, Antioxidant, Anticancer and anti-HCV Agents. Kucukguzel, S.G., I. Coskun, S. Aydin, G. Aktay, S. Gursoy, O. Cevik, O.B. Ozakpinar, D. Ozsavci, A. Sener, N. Kaushik-Basu, A. Basu, and T.T. Talele. Molecules, 2013. 18(3): p. 3595-3614. ISI[000316611700079].

[WOS]. OI_0510-052313.


28. Successful Establishment and Evaluation of a New Animal Model for Studying the Hepatitis B Virus YVDD Mutant. Ma, Y.-X., Z.-W. Song, X. Teng, L.-J. Fu, M.-L. Hao, S.-J. Chen, W.-Z. Xu, and H.-X. Gu. Archives of Virology, 2013. 158(4): p. 785-791. ISI[000317305200006].

[WOS]. OI_0510-052313.


29. Antimicrobial Activity and Composition Profile of Grape (Vitis vinifera) Pomace Extracts Obtained by Supercritical Fluids. Oliveira, D.A., A.A. Salvador, A. Smania, Jr., E.F.A. Smania, M. Maraschin, and S.R.S. Ferreira. Journal of Biotechnology, 2013. 164(3): p. 423-432. ISI[000317187400006].

[WOS]. OI_0510-052313.


30. Anti-Hepatitis B Virus Activity of alpha-DDB-DU, a Novel Nucleoside Analogue, in Vitro and in Vivo. Zheng, L.-Y., L.-M. Zang, Q.-H. Yang, W.-Q. Yu, X.-Z. Fang, Y.-H. Zhang, X.-J. Zhao, N. Wan, Y.-T. Zhang, Q.-D. Wang, and J.-B. Chang. European Journal of Pharmacology, 2013. 702(1-3): p. 258-263. ISI[000317153100033].

[WOS]. OI_0510-052313.


31. In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii. Bilgin, M., T. Yildirim, and M. Hokelek. Balkan Medical Journal, 2013. 30(1): p. 19-22. ISI[000317543300007].

[WOS]. OI_0510-052313.


32. Evaluation of anti-HCV Activity and SAR Study of (+)-Lycoricidine through Targeting of Host Heat-stress Cognate 70 (Hsc70). Chen, D.-Z., J.-D. Jiang, K.-Q. Zhang, H.-P. He, Y.-T. Di, Y. Zhang, J.-Y. Cai, L. Wang, S.-L. Li, P. Yi, Z.-G. Peng, and X.-J. Hao. Bioorganic & Medicinal Chemistry Letters, 2013. 23(9): p. 2679-2682. ISI[000317333900040].

[WOS]. OI_0510-052313.


33. Design, Synthesis and Structure-Activity Relationships of 3,5-Diaryl-1H-pyrazoles as Inhibitors of Arylamine N-Acetyltransferase. Fullam, E., J. Talbot, A. Abuhammed, I. Westwood, S.G. Davies, A.J. Russell, and E. Sim. Bioorganic & Medicinal Chemistry Letters, 2013. 23(9): p. 2759-2764. ISI[000317333900055].

[WOS]. OI_0510-052313.


34. Activities of Systemically Administered Echinocandins against in Vivo Mature Candida Albicans Biofilms Developed in a Rat Subcutaneous Model. Kucharkova, S., N. Sharma, I. Spriet, J. Maertens, P. Van Dijck, and K. Lagrou. Antimicrobial Agents and Chemotherapy, 2013. 57(5): p. 2365-2368. ISI[000317467600048].

[WOS]. OI_0510-052313.


35. A Cyclic Peptide Mimic of an RNA Recognition Motif of Human La Protein Is a Potent Inhibitor of Hepatitis C Virus. Manna, A.K., A. Kumar, U. Ray, S. Das, G. Basu, and S. Roy. Antiviral Research, 2013. 97(3): p. 223-226. ISI[000317709400001].

[WOS]. OI_0510-052313.


36. Design, Synthesis and Anti-tuberculosis Activity of 1-Adamantyl-3-Heteroaryl Ureas with Improved in Vitro Pharmacokinetic Properties. North, E.J., M.S. Scherman, D.F. Bruhn, J.S. Scarborough, M.M. Maddox, V. Jones, A. Grzegorzewicz, L. Yang, T. Hess, C. Morisseau, M. Jackson, M.R. McNeil, and R.E. Lee. Bioorganic & Medicinal Chemistry, 2013. 21(9): p. 2587-2599. ISI[000317403200017].

[WOS]. OI_0510-052313.


37. Discovery of a Novel Series of Non-nucleoside Thumb Pocket 2 HCV NS5B Polymerase Inhibitors. Stammers, T.A., R. Coulombe, J. Rancourt, B. Thavonekham, G. Fazal, S. Goulet, A. Jakalian, D. Wernic, Y. Tsantrizos, M.-A. Poupart, M. Boes, G. McKercher, L. Thauvette, G. Kukolj, and P.L. Beaulieu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(9): p. 2585-2589. ISI[000317333900021].

[WOS]. OI_0510-052313.


38. Synthesis and Evaluation as Antitubercular Agents of 5-Arylethenyl and 5-(Hetero)aryl-3-isoxazolecarboxylate. Vergelli, C., A. Cilibrizzi, L. Crocetti, A. Graziano, V. Dal Piaz, B. Wan, Y. Wang, S. Franzblau, and M.P. Giovannoni. Drug Development Research, 2013. 74(3): p. 162-172. ISI[000317522900002].

[WOS]. OI_0510-052313.


39. Anticandidal Activity and Biocompatibility of a Rechargeable Antifungal Denture Material. Villar, C.C., A.L. Lin, Z. Cao, X.R. Zhao, L.A. Wu, S. Chen, Y. Sun, and C.K. Yeh. Oral Diseases, 2013. 19(3): p. 287-295. ISI[000317490300008].

[WOS]. OI_0510-052313.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2023